Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
PTER-IN-1
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | PTER-IN-1 is a selective inhibitor of PTER that demonstrates specificity for HDACs. It elevates N-acetyltaurine levels in both lean and obese mice while reducing food intake in obese mice. PTER-IN-1 is useful for obesity research. |
| In vitro | PTER-IN-1 (Compound 41) is a potent and selective inhibitor of recombinant mouse PTER-mediated N-acetyltaurine hydrolysis, with selectivity over HDAC enzymes exceeding 250-fold. It shows only weak inhibitory activity against HDACs 1-11 and SIRTs 1-4, demonstrating high specificity for PTER. |
| In vivo | PTER-IN-1 (100 mg/kg; intraperitoneal injection; daily/single dose) in obese mice demonstrates a dose-dependent increase in plasma N-acetyltaurine levels, reduces food intake and body weight, decreases fat mass, enhances the weight loss efficacy of Semaglutide, and prevents weight regain after the cessation of GLP-1R agonist treatment. |
| Molecular Weight | 372.37 |
| Formula | C19H20N2O6 |
| Cas No. | 3114432-21-9 |
| Smiles | O=C(NO)CCOCCOCCN1C(=O)C=2C=CC=C3C=CC=C(C1=O)C32 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.